"At the Swedish Cancer Institute, our team works in a collaborative environment to focus on you - not your disease. We fight cancer using every available tool, from the rapidly developing science of gene sequencing to innovative treatments and therapies to the compassionate caring and support you and your loved ones deserve."

During the past decade, Swedish Cancer Institute Research conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Swedish Cancer Institute Research" are "Breast Cancer With Low to Intermediate HER2 Expression" (1 trials) and "Metastatic Castration-Resistant Prostate Cancer" (1 trials). Many other conditions were trialed in "Swedish Cancer Institute Research" in a lesser frequency.

Most popular intervention types in "Swedish Cancer Institute Research" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abiraterone" (1 trials), "Enzalutamide" (1 trials), "Leukine® (sargramostim, GM-CSF) and water for injection" (1 trials), "NeuVax™ vaccine" (1 trials) and "[Lu-177]-PNT2002" (1 trials). Other intervention names were less common.

The vast majority of trials in "Swedish Cancer Institute Research" are 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Swedish Cancer Institute Research". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Swedish Cancer Institute Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Swedish Cancer Institute Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".